Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Characterization of glial-restricted precursors from rhesus monkey embryonic stem cells.

Chen H, Mao Y, Wang S, Li B, Wang J, Li J, Ma Y.

Transl Neurosci. 2015 Nov 27;6(1):244-251. doi: 10.1515/tnsci-2015-0026. eCollection 2015.

2.

Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?

Myers SA, Bankston AN, Burke DA, Ohri SS, Whittemore SR.

Exp Neurol. 2016 Sep;283(Pt B):560-72. doi: 10.1016/j.expneurol.2016.04.009. Epub 2016 Apr 13. Review.

PMID:
27085393
3.

Edaravone combined with Schwann cell transplantation may repair spinal cord injury in rats.

Zhang SQ, Wu MF, Piao Z, Yao J, Li JH, Wang XG, Liu J.

Neural Regen Res. 2015 Feb;10(2):230-6. doi: 10.4103/1673-5374.152376.

4.

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.

Boomkamp SD, McGrath MA, Houslay MD, Barnett SC.

Br J Pharmacol. 2014 May;171(9):2385-98. doi: 10.1111/bph.12588.

5.

Human astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cord.

Haas C, Fischer I.

J Neurotrauma. 2013 Jun 15;30(12):1035-52. doi: 10.1089/neu.2013.2915. Epub 2013 Jun 12.

6.

Transplantation of D15A-expressing glial-restricted-precursor-derived astrocytes improves anatomical and locomotor recovery after spinal cord injury.

Fan C, Zheng Y, Cheng X, Qi X, Bu P, Luo X, Kim DH, Cao Q.

Int J Biol Sci. 2013;9(1):78-93. doi: 10.7150/ijbs.5626. Epub 2012 Dec 22.

7.

Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair.

Downing TL, Wang A, Yan ZQ, Nout Y, Lee AL, Beattie MS, Bresnahan JC, Farmer DL, Li S.

J Control Release. 2012 Aug 10;161(3):910-7. doi: 10.1016/j.jconrel.2012.05.034. Epub 2012 May 23.

8.

The roles of neuronal and glial precursors in overcoming chondroitin sulfate proteoglycan inhibition.

Ketschek AR, Haas C, Gallo G, Fischer I.

Exp Neurol. 2012 Jun;235(2):627-37. doi: 10.1016/j.expneurol.2012.03.017. Epub 2012 Apr 3.

9.

Phenotypic analysis of astrocytes derived from glial restricted precursors and their impact on axon regeneration.

Haas C, Neuhuber B, Yamagami T, Rao M, Fischer I.

Exp Neurol. 2012 Feb;233(2):717-32. doi: 10.1016/j.expneurol.2011.11.002. Epub 2011 Nov 10.

10.

Stem cells: novel players in the treatment of erectile dysfunction.

Zhang H, Albersen M, Jin X, Lin G.

Asian J Androl. 2012 Jan;14(1):145-55. doi: 10.1038/aja.2011.79. Epub 2011 Oct 17. Review.

11.

Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury.

Noble M, Davies JE, Mayer-Pröschel M, Pröschel C, Davies SJ.

Neurotherapeutics. 2011 Oct;8(4):677-93. doi: 10.1007/s13311-011-0071-z. Review.

12.

Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats.

Kim H, Zahir T, Tator CH, Shoichet MS.

PLoS One. 2011;6(6):e21744. doi: 10.1371/journal.pone.0021744. Epub 2011 Jun 30.

13.

Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury.

Jin Y, Neuhuber B, Singh A, Bouyer J, Lepore A, Bonner J, Himes T, Campanelli JT, Fischer I.

J Neurotrauma. 2011 Apr;28(4):579-94. doi: 10.1089/neu.2010.1626. Epub 2011 Mar 24.

Supplemental Content

Support Center